ProfileGDS5678 / 1449529_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 58% 58% 56% 57% 60% 58% 57% 57% 56% 57% 58% 59% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5450358
GSM967853U87-EV human glioblastoma xenograft - Control 23.4771158
GSM967854U87-EV human glioblastoma xenograft - Control 33.5129958
GSM967855U87-EV human glioblastoma xenograft - Control 43.3411956
GSM967856U87-EV human glioblastoma xenograft - Control 53.4176157
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.7026160
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5749658
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4602557
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.43657
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.4097256
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4654957
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4736758
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5379959
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4697258